These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34445314)

  • 21. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
    Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
    Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
    Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
    J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
    Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
    Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioengineered
    Fernández-Garibay X; Ortega MA; Cerro-Herreros E; Comelles J; Martínez E; Artero R; Fernández-Costa JM; Ramón-Azcón J
    Biofabrication; 2021 Apr; 13(3):. PubMed ID: 33836519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts.
    Pantic B; Borgia D; Giunco S; Malena A; Kiyono T; Salvatori S; De Rossi A; Giardina E; Sangiuolo F; Pegoraro E; Vergani L; Botta A
    Exp Cell Res; 2016 Mar; 342(1):39-51. PubMed ID: 26905645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA
    Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J
    J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
    Bargiela A; Sabater-Arcis M; Espinosa-Espinosa J; Zulaica M; Lopez de Munain A; Artero R
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25203-25213. PubMed ID: 31754023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
    Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
    Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.
    Sammons MA; Antons AK; Bendjennat M; Udd B; Krahe R; Link AJ
    PLoS One; 2010 Feb; 5(2):e9301. PubMed ID: 20174632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.
    López-Martínez A; Soblechero-Martín P; de-la-Puente-Ovejero L; Nogales-Gadea G; Arechavala-Gomeza V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32971903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
    Fugier C; Klein AF; Hammer C; Vassilopoulos S; Ivarsson Y; Toussaint A; Tosch V; Vignaud A; Ferry A; Messaddeq N; Kokunai Y; Tsuburaya R; de la Grange P; Dembele D; Francois V; Precigout G; Boulade-Ladame C; Hummel MC; Lopez de Munain A; Sergeant N; Laquerrière A; Thibault C; Deryckere F; Auboeuf D; Garcia L; Zimmermann P; Udd B; Schoser B; Takahashi MP; Nishino I; Bassez G; Laporte J; Furling D; Charlet-Berguerand N
    Nat Med; 2011 Jun; 17(6):720-5. PubMed ID: 21623381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy.
    Beaulieu D; Thebault P; Pelletier R; Chapdelaine P; Tarnopolsky M; Furling D; Puymirat J
    Neurobiol Dis; 2012 Jan; 45(1):122-9. PubMed ID: 21742035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
    Oana K; Oma Y; Suo S; Takahashi MP; Nishino I; Takeda S; Ishiura S
    Sci Rep; 2013; 3():2142. PubMed ID: 23828222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.